Progesterone Market Size 2024-2028
The progesterone market size is forecast to increase by USD 1.24 billion at a CAGR of 13% between 2023 and 2028.
- Progesterone is a crucial hormone used in various medical applications, most notably in hormonal contraceptives. The market for progesterone is witnessing significant growth due to several key factors. The increasing prevalence of breast cancer is driving the demand for progesterone drugs as they are used in hormone replacement therapy and cancer treatment. Furthermore, the rise in research and development of progesterone drugs is leading to the introduction of innovative products and treatments. However, stringent regulations imposed by regulatory bodies are posing challenges to market growth. Lupin, a leading pharmaceutical company, is one of the major players investing In the development of progesterone-based drugs. Insurance coverage for these drugs can also impact market growth as some plans may not fully cover the cost, making affordability a concern for some consumers. Overall, the market is expected to witness steady growth In the coming years, driven by these factors and the ongoing research and development efforts.
What will be the Size of the Progesterone Market During the Forecast Period?
- The market encompasses a range of applications in women's health, including hormone replacement therapy for menopause, infertility treatments, and the management of various hormonal disorders. Progesterone, a natural hormone, plays a crucial role In the menstrual cycle, pregnancy, and the prevention of endometrial cancer. Its synthetic counterpart is used in prescription drugs for similar indications. The market is driven by the increasing prevalence of hormonal disorders, such as endometriosis, infertility, and menopause. Additionally, the growing awareness of the role of hormones, including progesterone, in breast cancer and other cancers, as well as precursor lesions, is fueling demand for progesterone-based treatments.
- The market is also influenced by advancements In the knowledge of the kisspeptin system and its role in reproductive hormones, leading to potential new applications for progesterone. The market size is significant, with various sources estimating billions of dollars in revenue. Soybeans derivatives and Dioscorea villosa are among the natural sources of progesterone, while synthetic production methods are also utilized. The market is expected to continue growing due to the expanding applications of progesterone and the increasing demand for effective hormonal treatments. The International Agency for Research on Cancer (IARC) classifies certain progesterone-based drugs as having potential carcinogenic effects, which may pose a challenge to market growth.
How is this Progesterone Industry segmented and which is the largest segment?
The progesterone industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Type
- Synthetic progesterone
- Natural progesterone
- Geography
- North America
- Canada
- US
- Europe
- Germany
- UK
- France
- Italy
- Asia
- China
- India
- Japan
- South Korea
- Rest of World (ROW)
- North America
By Type Insights
- The synthetic progesterone segment is estimated to witness significant growth during the forecast period. The market is experiencing growth due to the rising prevalence of amenorrhea and increasing cases of female infertility, breast cancer, and other hormonal disorders. The high prevalence of female infertility, particularly in developing countries, is attributed to risk factors such as sexually transmitted diseases (STDs) and endometriosis. For instance, STDs account for 70% of pelvic inflammatory diseases, leading to tubal damage in India, according to the Ministry of Health and Family Welfare (MoHFW). Progesterone treatments are used for various applications, including hormone replacement therapies, fertility treatments, contraception, and the management of dysfunctional uterine bleeding and endometriosis. Progesterone is also used In the treatment of breast cancer and its precursor lesions, as well as In the management of menopause symptoms such as hot flashes and night sweats.
Get a glance at the market report of share of various segments Request Free Sample
The synthetic progesterone segment was valued at USD 643.20 million in 2018 and showed a gradual increase during the forecast period.
Regional Analysis
- North America is estimated to contribute 43% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Progesterone is a critical reproductive hormone involved In the menstrual cycle, pregnancy, and various women's health conditions. In the healthcare sector, progesterone is used for breast cancer screening, hormone treatments for infertility medications, and hormone replacement therapies, including bioidentical hormone therapy. Progesterone plays a role in managing conditions such as hypothalamic amenorrhea, Polycystic Ovary Syndrome (PCOS), endometrial cancer, and precursor lesions. Progesterone is available in various forms, including natural, injectable, oral, transdermal, branded, and generic. The US market dominates the North American market due to local players, supportive policies, high awareness, and technological innovations. New York, Pennsylvania, and Connecticut generate the highest revenue due to the increasing preference for hormonal contraceptives.
For more insights on the market size of various regions, Request Free Sample
Moreover, mountainous states, including Colorado, Arizona, Utah, Nevada, New Mexico, Wyoming, Idaho, and Montana, have a growing demand due to high teenage pregnancy rates and awareness. Progesterone is also used for cosmetic purposes, including anti-aging properties. Insurance coverage, hospital, retail, and online pharmacies distribute these prescription and over-the-counter (OTC) drugs. The market's growth is driven by hormonal disorders, menopause, uterine bleeding, and abnormal bleeding. The market includes key players such as Soybeans, Dioscorea villosa, and prescription drugs like Crinone and Prometrium.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise In the adoption of Progesterone Industry?
- Increasing prevalence of breast cancer is the key driver of the market. Progesterone, a natural hormone, plays a crucial role in women's health, particularly In the context of breast cancer. With breast cancer being the most frequently diagnosed cancer worldwide, according to the International Agency for Research on Cancer (IARC), the demand for hormonal treatments, including progesterone, is expected to rise. Progesterone is used to alleviate breast tenderness associated with breast cancer screening and treatment. Additionally, it has applications in female infertility medications, reproductive hormones, and hormone replacement therapies. Progesterone is also used In the treatment of hypothalamic amenorrhea, Polycystic Ovary Syndrome (PCOS), and endometriosis. Natural progesterone, derived from sources like soybeans and Dioscorea villosa, and synthetic progesterone are available in various forms, including injectable, oral, transdermal, branded, and generic drugs.
- Progesterone treatments are administered through hospitals, retail pharmacies, online pharmacies, and other channels. The hormone is used to address various conditions, including uterine bleeding, menopause, endometrial cancer, precursor lesions, and abnormal bleeding. Progesterone's anti-aging properties and cosmetic applications, such as addressing facial hair, baldness, and hot flashes, are also gaining popularity. Insurance coverage for these treatments may vary, and it is essential to consult with healthcare professionals for proper diagnosis and treatment.
What are the market trends shaping the Progesterone Industry?
- Rise in research and development of progesterone drugs is the upcoming market trend. The market is experiencing growth due to the unmet demand for new formulations of female infertility medications. One potential innovation is MVT-602, a drug that targets the kisspeptin system to stimulate reproductive hormones. Kisspeptin hormones have shown promise in treating reproductive disorders such as Polycystic Ovary Syndrome (PCOS) and hypothalamic amenorrhea (HA). In a recent study, MVT-602 was injected into 24 women to stimulate reproductive hormones from the kisspeptin system, which may improve fertility. This development, along with the potential for progesterone to treat breast cancer screening abnormalities, breast tenderness, facial hair growth, baldness, and menopause symptoms, is driving market growth.
- Additionally, progesterone treatments are used for uterine bleeding, endometrial cancer precursor lesions, and dysfunctional uterine bleeding. Progesterone is available in various forms, including natural, injectable, oral, transdermal, branded, and generic drugs. It is accessible through hospital pharmacies, retail pharmacies, and online pharmacies. Progesterone is also used in fertility treatments and contraception. The market for progesterone is expected to continue growing due to its diverse applications in women's health and hormonal disorders.
What challenges does the Progesterone Industry face during its growth?
- Stringent regulations is a key challenge affecting the industry growth. The market encompasses various branded and generic drugs approved for treating uterine bleeding and amenorrhea. Regulatory bodies, such as the FDA and EMA, impose rigorous regulations on drug approvals, which may hinder market expansion. To secure marketing authorization, applicants must submit comprehensive data in a New Drug Application (NDA), including pre-clinical study results, drug properties, and clinical safety profiles. Progesterone is used in hormone replacement therapies for menopause, infertility medications, and contraception. It also has cosmetic applications due to its anti-aging properties. Progesterone is naturally derived from soybeans or Dioscorea villosa, while synthetic versions are available as prescription drugs like Crinone and Prometrium.
- Progesterone treatments are used for various conditions, including breast cancer screening, hormonal disorders, and dysfunctional uterine bleeding. Additionally, it is used in assisted reproductive technologies and fertility treatments. Market dynamics include the prevalence of conditions like PCOS, endometriosis, and breast cancer, as well as insurance coverage and access to healthcare. The market includes both injectable and oral forms, as well as transdermal applications. Progesterone is also used In the treatment of hot flashes and night sweats associated with menopause and In the prevention of endometrial cancer and precursor lesions.
Exclusive Customer Landscape
The progesterone market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the progesterone market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, progesterone market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AbbVie Inc.
- Alkem Laboratories Ltd.
- Aquatic Group
- Bionpharma Inc.
- Blubell Pharma Group
- Cadila Pharmaceuticals Ltd.
- Caesar and Loretz GmbH
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- Estrellas Life Sciences Pvt. Ltd.
- Fagron NV
- Glenmark Pharmaceuticals Ltd.
- Hikma Pharmaceuticals Plc
- Intas Pharmaceuticals Ltd.
- Kiama Lifesciences
- Lupin Ltd.
- Organon and Co.
- PROCAPS S.A
- Teva Pharmaceutical Industries Ltd.
- Virtus Pharmaceuticals LLC
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Research Analyst Overview
Progesterone is a vital hormone In the female reproductive system, playing a crucial role In the menstrual cycle, pregnancy, and various other functions. This hormone is produced naturally In the body, primarily In the corpus luteum after ovulation. However, it is also available in synthetic forms for medical use. The market encompasses various applications, including women's health, fertility treatments, and hormone replacement therapies. Progesterone is essential for the maintenance of early pregnancy and the preparation of the uterus for implantation. In cases of infertility, exogenous progesterone is used to support ovulation and implantation. Progesterone is also used to treat various hormonal disorders, such as hypothalamic amenorrhea, polycystic ovary syndrome (PCOS), and dysfunctional uterine bleeding.
In addition, it is often prescribed to women experiencing menopause to alleviate symptoms like hot flashes and night sweats. Furthermore, progesterone is used to treat endometrial cancer and its precursor lesions. Progesterone's role extends beyond reproductive health. It is also used in cosmetic applications due to its anti-aging properties. Progesterone is believed to help maintain skin elasticity and reduce facial hair growth and baldness in women. The market comprises various forms of administration, including injectable, oral, transdermal, branded, and generic drugs. Prescription drugs dominate the market due to the need for medical supervision during treatment. However, over-the-counter (OTC) and online pharmacy options are also available for certain applications.
Moreover, progesterone is derived from various sources, including soybeans and the Mexican wild yam (Dioscorea villosa). Synthetic progesterone is also produced in laboratories. Crinone and Prometrium are well-known branded injectable progesterone products, while various oral and transdermal options are available. The market is influenced by several factors, including healthcare policies, insurance coverage, and patient preferences. The availability and affordability of various progesterone formulations impact market dynamics. Assisted reproductive technologies and contraceptive methods also affect the demand for progesterone In the fertility and contraception sectors. The market is expected to grow due to the increasing prevalence of hormonal disorders, the aging population, and the expanding use of progesterone in cosmetic applications.
However, concerns regarding the safety and long-term effects of hormone replacement therapies may limit market growth. The market is influenced by various factors, including healthcare policies, patient preferences, and technological advancements.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
160 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 13% |
|
Market growth 2024-2028 |
USD 1.24 billion |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
11.3 |
|
Key countries |
US, Canada, Germany, UK, China, France, Italy, Japan, India, and South Korea |
|
Competitive landscape |
Leading Companies, market growth and forecasting, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
What are the Key Data Covered in this Progesterone Market Research and Growth Report?
- CAGR of the Progesterone industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market's competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the progesterone market growth of industry companies
We can help! Our analysts can customize this progesterone market research report to meet your requirements.